Shares of ConvaTec Group PLC (LON:CTEC) have earned a consensus recommendation of “Hold” from the ten brokerages that are currently covering the stock, MarketBeat.com reports. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and four have issued a buy rating on the company. The average 12 month price objective among brokers that have updated their coverage on the stock in the last year is GBX 145.11 ($1.90).
A number of equities research analysts recently issued reports on CTEC shares. Peel Hunt raised ConvaTec Group to a “buy” rating and upped their target price for the company from GBX 150 ($1.96) to GBX 230 ($3.01) in a research note on Monday, March 25th. Citigroup started coverage on ConvaTec Group in a research note on Tuesday, April 30th. They issued a “neutral” rating and a GBX 138 ($1.80) target price on the stock. Barclays reaffirmed an “equal weight” rating and issued a GBX 130 ($1.70) target price (down previously from GBX 148 ($1.93)) on shares of ConvaTec Group in a research note on Wednesday, April 17th. JPMorgan Chase & Co. reaffirmed a “neutral” rating and issued a GBX 132 ($1.72) target price (down previously from GBX 135 ($1.76)) on shares of ConvaTec Group in a research note on Thursday, May 9th. Finally, Jefferies Financial Group reaffirmed a “buy” rating and issued a GBX 145 ($1.89) target price on shares of ConvaTec Group in a research note on Friday, May 3rd.
CTEC stock traded down GBX 1.60 ($0.02) on Wednesday, reaching GBX 141.50 ($1.85). The company had a trading volume of 2,412,885 shares, compared to its average volume of 5,440,000. ConvaTec Group has a 1 year low of GBX 113.25 ($1.48) and a 1 year high of GBX 240.50 ($3.14). The company has a current ratio of 2.73, a quick ratio of 1.72 and a debt-to-equity ratio of 101.69. The firm’s fifty day moving average price is GBX 141.87. The company has a market capitalization of $2.79 billion and a P/E ratio of 12.86.
ConvaTec Group Company Profile
ConvaTec Group Plc develops, manufactures, and markets medical products and technologies worldwide. It offers advanced wound dressings and skin care products for the management of chronic wounds resulting from various conditions, such as diabetes, immobility, and venous disease, as well as for traumatic injury, burns, invasive surgery, and other causes.
Recommended Story: Stock Symbols and CUSIP Explained
Receive News & Ratings for ConvaTec Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ConvaTec Group and related companies with MarketBeat.com's FREE daily email newsletter.